Clinical Trials
5 trialsNCT05948943 2026-05-12
EPIK-L1
Novartis
Phase 2/3 Recruiting
NCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT07246928 2026-04-30
US: Ultrasound
Delta University for Science and Technology
Phase NA Completed
NCT07189832 2026-04-28
Bleomycin Intralesional Injections of Cystic Hygromas
Delta University for Science and Technology
Phase NA Completed
NCT00010452 2015-03-25
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
FDA Office of Orphan Products Development
Phase 2/3 Completed